Skip to main content
Equibles

Alex Lobo

Head of Investor Relations

Aktis Oncology, Inc. (AKTS)

Equibles does not estimate personal net worth.

Get an email with a short summary when Aktis Oncology, Inc. publishes a filing, an earnings call transcript or a press release.

Get AKTS alerts

About Alex Lobo

Alex Lobo is recorded as Head of Investor Relations at Aktis Oncology, Inc. (AKTS). Alex Lobo has spoken on 2 investor events across 1 company, most recently for Aktis Oncology, Inc. on May 27, 2026. Aktis Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aktis Oncology, Inc. includes Glenn Gormley (Board Member).

Alex Lobo on recent calls

“So our question is related to the extrapolation of lutetium-177 to actinium-225, and specifically we're wondering how the translation accounts for the recoil effect of actinium-225 and potential release of isotope from the key leader upon emission of the first alpha particle, and also how that effect could impact the…”
Head of Investor Relations, Aktis Oncology: AKY-2519 Clinical Imaging and Dosimetry Data Conference Call ·
“Before we begin, I'd like to remind you that today's remarks will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.”
Head of Investor Relations, AKTIS ONCOLOGY: AKY-2519 CLINICAL IMAGING AND DOSIMETRY DATA CONFERENCE CALL ·

Affiliation history

Company network

Leadership on record at Aktis Oncology, Inc.

Recent activity